{
  "protocolSection": {
    "identificationModule": {
      "nctId": "NCT04510376",
      "orgStudyIdInfo": {
        "id": "OMZPRI1F"
      },
      "organization": {
        "fullName": "Omeza, LLC",
        "class": "INDUSTRY"
      },
      "briefTitle": "Allergy Potential of Omeza Collagen Matrix in Human Subjects Using the Skin Prick Method",
      "officialTitle": "A Safety Study to Assess the Allergy Potential of Omeza Collagen Matrix in Human Subjects Using the Skin Prick Method"
    },
    "statusModule": {
      "statusVerifiedDate": "2020-08",
      "overallStatus": "COMPLETED",
      "expandedAccessInfo": {
        "hasExpandedAccess": false
      },
      "startDateStruct": {
        "date": "2019-11-14",
        "type": "ACTUAL"
      },
      "primaryCompletionDateStruct": {
        "date": "2019-11-14",
        "type": "ACTUAL"
      },
      "completionDateStruct": {
        "date": "2019-11-14",
        "type": "ACTUAL"
      },
      "studyFirstSubmitDate": "2020-08-10",
      "studyFirstSubmitQcDate": "2020-08-10",
      "studyFirstPostDateStruct": {
        "date": "2020-08-12",
        "type": "ACTUAL"
      },
      "lastUpdateSubmitDate": "2020-08-10",
      "lastUpdatePostDateStruct": {
        "date": "2020-08-12",
        "type": "ACTUAL"
      }
    },
    "sponsorCollaboratorsModule": {
      "responsibleParty": {
        "type": "SPONSOR"
      },
      "leadSponsor": {
        "name": "Omeza, LLC",
        "class": "INDUSTRY"
      }
    },
    "oversightModule": {
      "oversightHasDmc": false,
      "isFdaRegulatedDrug": false,
      "isFdaRegulatedDevice": true,
      "isUnapprovedDevice": true,
      "isUsExport": false
    },
    "descriptionModule": {
      "briefSummary": "Single-center, monadic, one day study utilizing the skin prick method to assess the allergy potential of Omeza Collagen Matrix in Human Subjects"
    },
    "conditionsModule": {
      "conditions": [
        "Allergic Reaction"
      ]
    },
    "designModule": {
      "studyType": "INTERVENTIONAL",
      "phases": [
        "NA"
      ],
      "designInfo": {
        "allocation": "NON_RANDOMIZED",
        "interventionModel": "SINGLE_GROUP",
        "primaryPurpose": "BASIC_SCIENCE",
        "maskingInfo": {
          "masking": "NONE"
        }
      },
      "enrollmentInfo": {
        "count": 25,
        "type": "ACTUAL"
      }
    },
    "armsInterventionsModule": {
      "armGroups": [
        {
          "label": "Test article",
          "type": "EXPERIMENTAL",
          "interventionNames": [
            "Device: Test Article"
          ]
        },
        {
          "label": "Histamine Positive Skin Test Control",
          "type": "ACTIVE_COMPARATOR",
          "interventionNames": [
            "Other: Positive Control"
          ]
        },
        {
          "label": "Aqueous Negative Control",
          "type": "PLACEBO_COMPARATOR",
          "interventionNames": [
            "Other: Negative Control"
          ]
        }
      ],
      "interventions": [
        {
          "type": "DEVICE",
          "name": "Test Article",
          "description": "Omeza Collagen Matrix",
          "armGroupLabels": [
            "Test article"
          ]
        },
        {
          "type": "OTHER",
          "name": "Positive Control",
          "description": "1.0 mg/mL Histamine Base",
          "armGroupLabels": [
            "Histamine Positive Skin Test Control"
          ]
        },
        {
          "type": "OTHER",
          "name": "Negative Control",
          "description": "Aqueous Negative Control",
          "armGroupLabels": [
            "Aqueous Negative Control"
          ]
        }
      ]
    },
    "outcomesModule": {
      "primaryOutcomes": [
        {
          "measure": "Allergic Reaction",
          "description": "Response of at least 3-mm diameter (with equivalent erythema) more than negative control is required as proof of presence of cutaneous allergen specific IgE",
          "timeFrame": "20 minutes"
        }
      ],
      "secondaryOutcomes": [
        {
          "measure": "Allergic Reaction",
          "description": "Latent reaction to skin prick (safety assessment)",
          "timeFrame": "60 minutes"
        }
      ]
    },
    "eligibilityModule": {
      "eligibilityCriteria": "Inclusion Criteria:\n\n1. Healthy volunteers aged 18 years of age and older as demonstrated by selfreported medical history, concurrent medication, and a brief dermal skin assessment of the test sites;\n2. Fully informed of the risks of entering the study and willing to provide written informed consent and HIPAA authorization to disclose protected health information;\n3. Subject has normal healthy skin on the either volar forearm.\n\nExclusion Criteria:\n\nSubjects must be excluded if any of the following conditions exist:\n\n1. Self-reported pregnant or nursing at the screening visit;\n2. Clinically significant skin disease which may contraindicate participation, including psoriasis, eczema, atopic dermatitis, and active cancer;\n3. History of drug abuse or current drug user;\n4. Treatment with antihistamine or steroid (any route) administered within the last 7 days;\n5. History of anaphylaxis to matrix ingredients (e.g. fish, palm oil, hemp oil, beeswax);\n6. Persistent severe/ unstable asthma;\n7. Subjects on beta blockers and/or ACE inhibitors;\n8. Medical condition which in the opinion of the Investigator would compromise the safety of the subject or confound study results (Subjects with the following conditions: chronic renal failure, CVA, cancer, spinal cord injury, diabetic neuropathy, recent anaphylaxis, limbs affected by lymphoedema, paralysis, or neurogenic abnormalities;\n9. Diabetic (type 1 or 2);\n10. Subjects taking the following: Antidepressants such as doxepin, other tricyclics, Phenothiazines, and tetracyclics within the last two weeks;\n11. Subjects taking OTC cold and flu remedies, \"sinus\" analgesics, antitussives, antiemetics, sedatives, relaxants, migraine prophylactics (cyproheptadine, pizotifen);\n12. Prolonged use of topical corticosteroids;\n13. Use of topical moisturizers on the volar forearms;\n14. Dermographism \"writing on the skin\" - common localized hive reaction, characterized by the abrupt onset of welts and hives where the skin is exposed to pressure, scratching, itching, or stroking;\n15. Investigator deems the subject an unsuitable candidate for this study.",
      "healthyVolunteers": true,
      "sex": "ALL",
      "minimumAge": "18 Years",
      "stdAges": [
        "ADULT",
        "OLDER_ADULT"
      ]
    },
    "contactsLocationsModule": {
      "overallOfficials": [
        {
          "name": "Lynne Ellis, M.D.",
          "affiliation": "PCR Corp",
          "role": "PRINCIPAL_INVESTIGATOR"
        },
        {
          "name": "Lori Decaro",
          "affiliation": "PCR Corp",
          "role": "STUDY_DIRECTOR"
        }
      ],
      "locations": [
        {
          "facility": "PCR Corp",
          "city": "St. Petersburg",
          "state": "Florida",
          "zip": "33702",
          "country": "United States",
          "geoPoint": {
            "lat": 27.77086,
            "lon": -82.67927
          }
        }
      ]
    },
    "referencesModule": {
      "seeAlsoLinks": [
        {
          "label": "Allergy Diagnostic Testing: An Updated Practice Parameter",
          "url": "https://www.aaaai.org/Aaaai/media/MediaLibrary/PDF%20Documents/Practice%20and%20Parameters/allergydiagnostictesting.pdf"
        }
      ]
    },
    "ipdSharingStatementModule": {
      "ipdSharing": "NO"
    }
  },
  "derivedSection": {
    "miscInfoModule": {
      "versionHolder": "2026-02-04",
      "submissionTracking": {
        "estimatedResultsFirstSubmitDate": "2021-04-05",
        "submissionInfos": [
          {
            "releaseDate": "2021-04-05",
            "resetDate": "2021-04-29",
            "mcpReleaseN": 1
          },
          {
            "releaseDate": "2023-02-23",
            "resetDate": "2023-03-22",
            "mcpReleaseN": 2
          },
          {
            "releaseDate": "2023-04-04",
            "resetDate": "2023-04-25",
            "mcpReleaseN": 3
          },
          {
            "releaseDate": "2023-04-26",
            "resetDate": "2023-05-16",
            "mcpReleaseN": 4
          },
          {
            "releaseDate": "2023-05-31",
            "resetDate": "2023-06-21",
            "mcpReleaseN": 5
          },
          {
            "releaseDate": "2024-06-18",
            "resetDate": "2024-07-11",
            "mcpReleaseN": 6
          }
        ]
      }
    },
    "conditionBrowseModule": {
      "meshes": [
        {
          "id": "D006967",
          "term": "Hypersensitivity"
        }
      ],
      "ancestors": [
        {
          "id": "D007154",
          "term": "Immune System Diseases"
        }
      ]
    }
  },
  "hasResults": false
}